Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis? Reply

Crit Care. 2023 Jun 8;27(1):225. doi: 10.1186/s13054-023-04513-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Case-Control Studies
  • Diabetes Mellitus, Type 2*
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Intensive Care Units
  • Sepsis* / drug therapy
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Hypoglycemic Agents
  • Glucose
  • Symporters